These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9001400)

  • 1. Identification and expression of a variant isoform of the levocabastine-sensitive neurotensin receptor in the mouse central nervous system.
    Botto JM; Sarret P; Vincent JP; Mazella J
    FEBS Lett; 1997 Jan; 400(2):211-4. PubMed ID: 9001400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.
    Mazella J; Botto JM; Guillemare E; Coppola T; Sarret P; Vincent JP
    J Neurosci; 1996 Sep; 16(18):5613-20. PubMed ID: 8795617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system.
    Perron A; Sarret P; Gendron L; Stroh T; Beaudet A
    J Biol Chem; 2005 Mar; 280(11):10219-27. PubMed ID: 15637074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning of a levocabastine-sensitive neurotensin binding site.
    Chalon P; Vita N; Kaghad M; Guillemot M; Bonnin J; Delpech B; Le Fur G; Ferrara P; Caput D
    FEBS Lett; 1996 May; 386(2-3):91-4. PubMed ID: 8647296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: binding properties, photoaffinity labeling, and internalization mechanism.
    Botto JM; Chabry J; Sarret P; Vincent JP; Mazella J
    Biochem Biophys Res Commun; 1998 Feb; 243(2):585-90. PubMed ID: 9480852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization.
    Lépée-Lorgeoux I; Betancur C; Rostène W; Pélaprat D
    Brain Res Dev Brain Res; 1999 Mar; 113(1-2):115-31. PubMed ID: 10064881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
    Vita N; Oury-Donat F; Chalon P; Guillemot M; Kaghad M; Bachy A; Thurneyssen O; Garcia S; Poinot-Chazel C; Casellas P; Keane P; Le Fur G; Maffrand JP; Soubrie P; Caput D; Ferrara P
    Eur J Pharmacol; 1998 Nov; 360(2-3):265-72. PubMed ID: 9851594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Administration of Levocabastine, a NTS2 Receptor Antagonist, Modifies Na(+), K(+)-ATPase Properties.
    Gutnisky A; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Neurochem Res; 2016 Jun; 41(6):1274-80. PubMed ID: 26738992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic-based differences in neurotensin levels and receptors in brains of LS x SS mice.
    Erwin VG; Radcliffe R; Hinkle B; Jones BC
    Peptides; 1993; 14(4):821-8. PubMed ID: 8234031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of neurotensin-stimulated phosphoinositide hydrolysis in brain regions of long sleep and short sleep mice.
    Erwin VG; Radcliffe RA
    Brain Res; 1993 Nov; 629(1):59-66. PubMed ID: 7904533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor.
    Vita N; Laurent P; Lefort S; Chalon P; Dumont X; Kaghad M; Gully D; Le Fur G; Ferrara P; Caput D
    FEBS Lett; 1993 Feb; 317(1-2):139-42. PubMed ID: 8381365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recycling ability of the mouse and the human neurotensin type 2 receptors depends on a single tyrosine residue.
    Martin S; Vincent JP; Mazella J
    J Cell Sci; 2002 Jan; 115(Pt 1):165-73. PubMed ID: 11801734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin.
    Navarro V; Martin S; Sarret P; Nielsen MS; Petersen CM; Vincent J; Mazella J
    FEBS Lett; 2001 Apr; 495(1-2):100-5. PubMed ID: 11322955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain.
    Schotte A; Leysen JE; Laduron PM
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):400-5. PubMed ID: 3022160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and molecular characterization of the neurotensin receptor expressed in Sf9 cells.
    Boudin H; Labrecque J; Lhiaubet AM; Dennis M; Rostène W; Pélaprat D
    Biochem Pharmacol; 1996 May; 51(9):1243-6. PubMed ID: 8645349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The partial agonist properties of levocabastine in neurotensin-induced analgesia.
    Dubuc I; Remande S; Costentin J
    Eur J Pharmacol; 1999 Sep; 381(1):9-12. PubMed ID: 10528128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells.
    Yamada M; Yamada M; Lombet A; Forgez P; Rostène W
    Life Sci; 1998; 62(23):PL 375-80. PubMed ID: 9627096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
    Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in expression levels of neurotensin precursor and receptor mRNA in chicken intestinal tissues and liver during late embryonic and early posthatching development.
    Tanaka M; Nakao N; Yamamoto I; Tsushima N; Ohta Y
    Poult Sci; 2013 Oct; 92(10):2765-71. PubMed ID: 24046425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
    Richard F; Barroso S; Martinez J; Labbé-Jullié C; Kitabgi P
    Mol Pharmacol; 2001 Dec; 60(6):1392-8. PubMed ID: 11723247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.